使PARP-1/2

Xiaoyu Wang1, Chengyan Wang2, Jinruo Li3

  • 1Institute of Material Medical: Chinese Academy of Medical Sciences & Peking Union Medical College Institute of Materia Medica, synthetic medicinal chemistry, CHINA.

ChemMedChem
|April 9, 2025
PubMed
概括

研究人员开发了一种新型的pyrazolo[1,5-a]pyrimidine-3-carboxamide化合物 (化合物A),该化合物与Poly (ADP-ribose) 聚合酶-1/2 (PARP-1/2) 结合. 它独特的结合方式为开发针对PARP-1或PARP-2的新癌症治疗提供了基础.